Daniel R. Hart - 14 Mar 2023 Form 4 Insider Report for Avid Bioservices, Inc.

Role
Chief Financial Officer
Signature
/s/ Daniel R. Hart
Issuer symbol
N/A
Transactions as of
14 Mar 2023
Net transactions value
-$83,680
Form type
4
Filing time
16 Mar 2023, 19:59:18 UTC
Previous filing
11 Jan 2023
Next filing
07 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Sale $57,000 -3,000 -6% $19.00 46,957 14 Mar 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Options Exercise $11,320 +2,000 +4.3% $5.66 48,957 14 Mar 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale $38,000 -2,000 -4.1% $19.00 46,957 14 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Stock Option(right to buy) Options Exercise $0 -2,000 -0.86% $0.000000 230,380 14 Mar 2023 Common Stock 2,000 $5.66 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2022.
F2 Stock option granted to the reporting person on August 1, 2018 vested in four (4) equal annual installments and was fully-vested as of August 1, 2022.